Form 4: CytoDyn Inc. (CYDY), Colachis Arian, transaction 09/30/2020
Summary
A Form 4 filed with the Securities and Exchange Commission by Arian Colachis, an officer of CytoDyn Inc. (CYDY) with the title "GC and Corporate Secretary". It reports the acquisition on 09/30/2020 of 70,000 shares represented by restricted stock units under the Amended & Restated 2012 Equity Incentive Plan, which made up the whole direct holding, and a non-qualified stock option for 150,000 shares at $3.12, expiring 06/15/2030. The option was approved by a board committee on June 15, 2020 subject to stockholder approval of the plan, obtained on September 30, 2020, and vests annually in three equal installments beginning June 15, 2021. The form is signed by Arian Colachis and dated 10/02/2020.
Summary drafted by a model from the document's text below and checked by script against that text before publication. It is a navigation aid, not a reading of what the document proves. Where AI is used
Cite this document
“Form 4: CytoDyn Inc. (CYDY), Colachis Arian, transaction 09/30/2020.”
Original at www.sec.gov. Archived at Pandemic Darlings, https://pandemicdarlings.com/source-documents/sec-cydy-4-filed2020-10-02-0001807094-20-000021-548911098a/
, SHA-256 5af2b2d9edb6947fed8a499a8e4e750d4d769c500c4e820efaddf795cf21d271.Full text
SEC Form 4 FORM 4 | UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934 or Section 30(h) of the Investment Company Act of 1940 | OMB APPROVAL OMB Number: 3235-0287 Estimated average burden hours per response: 0.5 | OMB APPROVAL | OMB Number: 3235-0287 Estimated average burden hours per response: 0.5 | OMB Number: | 3235-0287 | Estimated average burden | hours per response: | 0.5 Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b). 1. Name and Address of Reporting Person * Colachis Arian (Last) (First) (Middle) 1111 MAIN STREET SUITE 660 (Street) VANCOUVER WA 98660 (City) (State) (Zip) | Colachis Arian | (Last) | (First) | (Middle) | 1111 MAIN STREET | SUITE 660 | VANCOUVER | WA | 98660 | (City) | (State) | (Zip) | 2. Issuer Name and Ticker or Trading Symbol CytoDyn Inc. [ CYDY ] | 5. Relationship of Reporting Person(s) to Issuer (Check all applicable) Director 10% Owner X Officer (give title below) Other (specify below) GC and Corporate Secretary | Director | 10% Owner | X | Officer (give title below) | Other (specify below) | GC and Corporate Secretary 3. Date of Earliest Transaction (Month/Day/Year) 09/30/2020 4. If Amendment, Date of Original Filed (Month/Day/Year) | 6. Individual or Joint/Group Filing (Check Applicable Line) X Form filed by One Reporting Person Form filed by More than One Reporting Person | X | Form filed by One Reporting Person | Form filed by More than One Reporting Person Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned 1. Title of Security (Instr. 3) | 2. Transaction Date (Month/Day/Year) | 2A. Deemed Execution Date, if any (Month/Day/Year) | 3. Transaction Code (Instr. 8) | 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) | 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) | 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) | 7. Nature of Indirect Beneficial Ownership (Instr. 4) Code | V | Amount | (A) or (D) | Price Common Stock | 09/30/2020 | A | 70,000 (1) | A | (2) | 70,000 | D Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities) 1. Title of Derivative Security (Instr. 3) | 2. Conversion or Exercise Price of Derivative Security | 3. Transaction Date (Month/Day/Year) | 3A. Deemed Execution Date, if any (Month/Day/Year) | 4. Transaction Code (Instr. 8) | 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) | 6. Date Exercisable and Expiration Date (Month/Day/Year) | 7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) | 8. Price of Derivative Security (Instr. 5) | 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) | 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) | 11. Nature of Indirect Beneficial Ownership (Instr. 4) Code | V | (A) | (D) | Date Exercisable | Expiration Date | Title | Amount or Number of Shares Non-qualified Stock Option | $ 3.12 | 09/30/2020 (3) | A | 150,000 | (4) | 06/15/2030 | Common Stock | 150,000 | $ 0 | 150,000 | D Explanation of Responses: 1. Represents restricted stock units granted pursuant to the Issuer's Amended & Restated 2012 Equity Incentive Plan. 2. Not applicable. 3. The option grant was approved by a committee of the Issuer's Board of Directors on June 15, 2020, subject to stockholder approval of the Issuer's Amended & Restated 2012 Equity Incentive Plan (the "Plan") under which the option was granted. The Issuer's stockholders approved the Plan on September 30, 2020. 4. The stock option vests annually in three equal installments beginning June 15, 2021. Arian Colachis | 10/02/2020 ** Signature of Reporting Person | Date Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly. * If the form is filed by more than one reporting person, see Instruction 4 (b)(v). ** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a). Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure. Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
File and source
- File
- SEC_CYDY_4_filed2020-10-02_0001807094-20-000021.xml
- Size
- 16,539 bytes
- SHA-256
- 5af2b2d9edb6947fed8a499a8e4e750d4d769c500c4e820efaddf795cf21d271
- Original
- www.sec.gov